Hedge Fund - Propel Bio Management
Akero Therapeutics Inc. (AKRO)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $0 | 0% | 0 | $53.18 |
| 2 | 2025 - Q3 (2025-09-30) | $10,867,412 | 10.88% | 228,884 | $48.42 |
| 3 | 2025 - Q2 (2025-06-30) | $12,213,250 | 14.82% | 228,884 | $45.44 |
| 4 | 2025 - Q1 (2025-03-31) | $9,265,224 | 10.76% | 228,884 | $42.39 |
| 5 | 2024 - Q4 (2024-12-31) | $9,562,541 | 9.49% | 343,729 | $30.29 |
| 6 | 2024 - Q3 (2024-09-30) | $9,861,585 | 5.71% | 343,729 | $26.07 |
| 7 | 2024 - Q2 (2024-06-30) | $7,689,062 | 4.98% | 327,752 | $21.39 |
| 8 | 2024 - Q1 (2024-03-31) | $8,279,016 | 4.81% | 327,752 | $24.02 |
| 9 | 2023 - Q4 (2023-12-31) | $2,336,214 | 1.93% | 100,052 | $19.72 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center